@ARTICLE{
author={Rudin CM,Dowlati A,Chen Y,Navarro Mendivil AF,Yang JC-H,Stojanovic Goran,Rich P,Andric Zoran G,Wu Y-L,Chen H,Zhang L,Yeung S,Benzaghou FM,Paz-Ares L,Bunn PA},
year={2023},
title={RESILIENT part 2: A randomized, open-label phase III study of liposomal irinotecan versus topotecan in adults with relapsed small cell lung cancer (SCLC)},
journal={JOURNAL OF THORACIC ONCOLOGY},
volume={18},
number={4},
pages={S129-S130},
document_type={Meeting Abstract},
}